Table 4.
Clinical diagnoses and TH positive area fraction
| Disease | Number of Diagnoses |
Mean (%) |
Median (%) |
Max (%) |
Min (%) |
First Quartile (%) |
Third Quartile (%) |
|---|---|---|---|---|---|---|---|
| Hypertension and/or Cardiovascular disease (20 Total Cases) | |||||||
| Hypertension | 12 | 7.22 | 6.09 | 0.01 | 22.35 | 2.27 | 9.53 |
| CAD and/or MI | 10 | 4.58 | 2.97 | 0.01 | 15.08 | 0.74 | 7.02 |
| Atrial Fibrillation | 4 | 9.59 | 8.00 | 0.01 | 22.35 | 5.36 | 12.23 |
| Sudden Cardiac Death | 3 | 2.49 | 0.07 | 0.01 | 7.39 | 0.04 | 3.73 |
| Ventricular Tachycardia | 2 | 7.01 | 7.01 | 6.63 | 7.39 | 6.82 | 7.20 |
| Neurodegenerative Disease (12 Total Cases) | |||||||
| Alzheimer's Disease | 11 | 5.44 | 5.22 | 0.22 | 15.08 | 2.30 | 6.89 |
| Parkinson Disease | 2 | 6.37 | 6.37 | 3.57 | 9.17 | 4.97 | 7.77 |
| Huntington Disease | 1 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 |
| Multiple System Atrophy | 1 | 6.50 | 6.50 | 6.50 | 6.50 | 6.50 | 6.50 |
| Diseases Related to Vagus Nerve Stimulation Therapy (10 Total Cases) | |||||||
| CHF | 4 | 8.72 | 8.12 | 3.57 | 15.08 | 6.43 | 10.41 |
| Depression | 7 | 3.47 | 2.33 | 0.87 | 9.17 | 2.06 | 3.92 |
| Cases Not Included in the Above Groups (5 Total Cases) | |||||||
| None of the above Diagnoses | 5 | 3.44 | 0.79 | 0.34 | 9.50 | 0.45 | 6.13 |
TH: anti-Tyrosine Hydroxylase antibodies, CAD: Coronary artery disease, MI: Myocardial infarction, CHF: Chronic heart failure